Literature DB >> 8074445

Apoptosis of human primary and metastatic colon adenocarcinoma cell lines in vitro induced by 5-fluorouracil, verapamil, and hyperthermia.

I B Shchepotin1, V Soldatenkov, R R Buras, R J Nauta, M Shabahang, S R Evans.   

Abstract

Combined verapamil(V) and hyperthermia(HT) showed a significant decrease in HT29 and SW-620 cell counts by 61.5% and 77.6%, respectively, when compared to control. V in conjunction with 5-FU significantly reduced HT-29 count by 37% in comparison to 5-FU alone, and did not enhance the growth inhibitory effect of 5-FU on SW-620. HT did not enhance the growth inhibition seen with 5-FU treatment alone on HT-29, while this combination significantly decreased SW-620 cell count by 28.9% in comparison to administration of 5-FU alone. Joint administration of V and HT with 5-FU appeared to have a possible synergistic effect and reduced HT-29 count by 90% when compared to control. 5-FU alone or in different combinations with V and HT, as well as combination V+HT, results in apoptosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8074445

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Physical PEGylation Enhances The Cytotoxicity Of 5-Fluorouracil-Loaded PLGA And PCL Nanoparticles.

Authors:  Abdelkader E Ashour; Mohammad Badran; Ashok Kumar; Tajamul Hussain; Ibrahim A Alsarra; Alaa Eldeen B Yassin
Journal:  Int J Nanomedicine       Date:  2019-11-28

2.  Analysis of histological therapeutic effect, apoptosis rate and p53 status after combined treatment with radiation, hyperthermia and 5-fluorouracil suppositories for advanced rectal cancers.

Authors:  C Sakakura; K Koide; D Ichikawa; T Wakasa; M Shirasu; A Kimura; H Taniguchi; A Hagiwara; T Yamaguchi; J Inazawa; T Abe; T Takahashi; E Otsuji
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

3.  Long-term use of calcium channel blocking drugs and breast cancer risk in a prospective cohort of US and Puerto Rican women.

Authors:  Lauren E Wilson; Aimee A D'Aloisio; Dale P Sandler; Jack A Taylor
Journal:  Breast Cancer Res       Date:  2016-07-05       Impact factor: 6.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.